However, it should be noted that different DC subpopulations can stimulate different immune responses, so CD205 antibody recognizing CD8+ DCs and 33D1 antibody recognizing CD8− DCs can ultimately stimulate different anti-tumor immune responses. Here, CD8A is linked to neoplasm.